Skip to main content

Drug utilization review educational bulletins

Recently published Medi-Cal bulletins

September 2022

 

Insulin Biosimilars, Follow-Ons, and Authorized Generics (PDF)

 

Assuring the Safe Use of Melatonin in Children (PDF)

 

May 2022

 

Submitting Quality Data to the California Immunization Registry (CAIR2) (PDF)

 

March 2022

 

Improving the Quality of Care: Legislative Impact on the Use of Naloxone (PDF)

 

February 2022

 

Professional Organizations Push for Recall of Buprenorphine Dental Warning (PDF)

 

January 2022

 

Rare but significant risk of Diabetic Ketoacidosis associated with SGLT2 inhibitors

 

Metabolic Monitoring for Children and Adolescents on Antipsychotics

 

Using Ivermectin for COVID-19 virus

 

September 2021

 

UPDATED: Drug Safety Communication: Voluntary Recall of Varenicline (Chantix) Due to Nitrosamine (PDF)


 
2021 Immunization Updates: COVID-19, Influenza, and Meningococcal Disease (PDF)

 

August 2021

 

Drug Safety Communication: FDA Requests Removal of Pregnancy Contraindication for Statins (PDF)

 

April 2021

 

Drug Safety Communication: Potential Increased Arrhythmia Risk from Lamotrigine (PDF)

 

March 2021

 

Clinical Review: Recommendations for the Tapering of Benzodiazepines (PDF)

 

January 2021

 

Clinical Review: Recommendations for the Management of Acute Dental Pain (PDF)

 

August 2020

 

Clinical Review: 2020 Standards of Care for Treatment of Type 2 Diabetes (PDF)

 

August 2019

 

CDC, ACIP release flu vaccine recommendations for upcoming flu season (PDF)

 

CDC, ACIP release human papillomavirus vaccination for adults: updated recommendations (PDF)

 

 

July 2019

 

CDC releases interim infection prevention and control recommendations for measles

 

California drug take-back program


Accelerating opioid safety: ambulatory care toolkit (PDF)

 

 

July 2018

 

Drug safety communication: adverse effects from fluoroquinolone antibiotics (PDF)

 

 

March 2018

 

In the pharmacy: pharmacists furnishing nicotine replacement products (PDF)

 

 

February 2018

 

Drug safety communication: new age limit for opioid cough and cold medicines (PDF)

 

 

September 2017

 

Alert: online report to the Vaccine Adverse Event Reporting System (VAERS) (PDF)


2017 immunization updates: influenza, HepA, meningococcal, HPV, adult vaccines (PDF)

Also of interest: